Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy with Inflammatory Bowel Disease: Stop the Disease, not the Drug!-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy with Inflammatory Bowel Disease: Stop the Disease, not the Drug!

Published:2024-06 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Torres Joana^ORCID,Mahadevan Uma

Publisher

Elsevier BV

Reference17 articles.

1. Inflammatory bowel disease increases risk of adverse pregnancy outcomes: a meta-analysis;O'Toole;Dig Dis Sci,2015

2. Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease;Tandon;Aliment Pharmacol Ther,2020

3. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure;Bröms;Inflamm Bowel Dis,2014

4. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease;Mahadevan;Gastroenterology,2021

5. Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010-2018;Meyer;Aliment Pharmacol Ther,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP